Strong demand for wealth, retirement and legacy products, paired with changing capital regimes are pushing Asian life insurers toward equities and alternative assets as industry investments surge.
The proposed protected cell company framework could broaden access to captive insurance arrangements and facilitate insurance-linked securities transactions.